7-117548628-GTTTTTT-GTTTT
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP5BA1
The NM_000492.4(CFTR):c.1210-7_1210-6delTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0293 in 1,547,804 control chromosomes in the GnomAD database, including 354 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000492.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CFTR | NM_000492.4 | c.1210-7_1210-6delTT | splice_region_variant, intron_variant | Intron 9 of 26 | ENST00000003084.11 | NP_000483.3 | ||
| CFTR-AS1 | NR_149084.1 | n.222-6091_222-6090delAA | intron_variant | Intron 2 of 2 |
Ensembl
Frequencies
GnomAD3 genomes 0.0357 AC: 5089AN: 142494Hom.: 122 Cov.: 31
GnomAD3 exomes AF: 0.0223 AC: 4575AN: 205052Hom.: 13 AF XY: 0.0219 AC XY: 2449AN XY: 111880
GnomAD4 exome AF: 0.0286 AC: 40213AN: 1405206Hom.: 232 AF XY: 0.0278 AC XY: 19403AN XY: 699172
GnomAD4 genome 0.0357 AC: 5090AN: 142598Hom.: 122 Cov.: 31 AF XY: 0.0351 AC XY: 2439AN XY: 69528
ClinVar
Submissions by phenotype
Cystic fibrosis Pathogenic:5Uncertain:1Other:1
This sequence change, also referred to as 5T;TG11 or TG11-5T in the literature, consists of 11 TG and 5 T sequence repeats on the same chromosome, and is located in intron 9 of the CFTR gene. It does not directly change the encoded amino acid sequence of the CFTR protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. The TG[11]T[5] allele has been observed in males with congenital bilateral absence of the vas deferens (CBAVD), with a penetrance of ~32%, when present on the opposite chromosome (in trans) from a severe pathogenic CFTR variant (PMID: 14685937). The TG[11]T[5] allele is not expected to cause cystic fibrosis in either males or females when in trans with a severe pathogenic CFTR variant (PMID: 14685937, 27447098), although individuals with borderline sweat chloride results and/or mild respiratory disease have been reported (PMID: 16778595). The combination of the TG[11]T[5] allele in trans with another 5T allele (TG11-13), is unlikely to be associated with CFTR-related symptoms (PMID: 21520337, 34196078). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies demonstrate that the 5T allele leads to exclusion of exon 10 (referred to as exon 9 in some publications) from the mRNA, which ultimately results in a non-functional CFTR protein (PMID: 7691356, 7684641, 10556281, 14685937, 21658649) and partial loss of function. Importantly, the number of TG repeats (11, 12 or 13) modifies the extent of exon 10 skipping when in cis with the 5T allele (PMID: 14685937, 10556281, 9435322). In a mini-gene assay, the percentage of CFTR mRNA without exon 10 was 54% for TG[11]T[5], 72% for TG[12]T[5] and 100% for TG[13]T[5] (PMID: 10556281). In summary, this variant is reported to cause disease. However, as this variant is associated with a lower penetrance than other pathogenic alleles in the CFTR gene, it has been classified as Pathogenic (low penetrance). -
The severity of lung disease in individuals heterozygous or homozygous for p.Arg117His depends on the presence of a variation in the poly T tract of intron 9, c.1210-12T[5_9] [Massie et al 2001]. Individuals with a CF-causing variant plus the 5T variant in cis with p.Arg117His usually develop the lung disease of CF, but those individuals with p.Arg117His and the 7T variant or the 9T variant have a highly variable phenotype that can range from no symptoms to mild lung disease [Kiesewetter et al 1993, Chmiel et al 1999]. -
- -
The 5T variant, located in intron 9 of the CFTR gene, is an alteration within the poly-thymidine tract, which decreases the efficiency of exon 10 splicing. The 5T variant in trans with a pathogenic CFTR mutation, or in the homozygous state, has been associated with CFTR-related disorders, including bronchiectasis (Sosnay PR et al. Pediatr. Clin. North Am., 2016 08;63:585-98), acute recurrent or chronic pancreatitis (Werlin S et al. J. Pediatr. Gastroenterol. Nutr., 2015 May;60:675-9; Masson E et al. PLoS ONE, 2013 Aug;8:e73522), and congenital bilateral absence of the vas deferens (CBAVD) (Bombieri C et al. J. Cyst. Fibros., 2011 Jun;10 Suppl 2:S86-102). The effect of 5T on exon 10 splicing is influenced by the adjacent TG tract, which usually consists of 11, 12, or 13 TG repeats. Increasing TG tract length correlates with decreased amount of full-length CFTR, thereby leading to higher likelihood of a cystic fibrosis phenotype (Sosnay PR et al. Pediatr. Clin. North Am., 2016 08;63:585-98); information regarding the number of TG repeats adjacent to the 5T allele is limited in pancreatitis and bronchiectasis research (Mantovani V et al. Clin. Chem., 2007 Mar;53:531-3; Bombieri C et al. J. Cyst. Fibros., 2011 Jun;10 Suppl 2:S86-102). -
- -
- -
NM_000492.3(CFTR):c.1210-7_1210-6delTT(aka IVS8-5T or 5T) is a variant within the polyT tract located within intron 8 of the CFTR gene. 5T has been observed in individuals diagnosed with cystic fibrosis but has also been observed in healthy individuals (PMID 23974870; gnomAD: AFR 7.085%). Please note that 5T is not associated with cystic fibrosis when detected in isolation and the American College of Medical Genetics does not recommend reporting 5T status through routine carrier screening when detected in isolation. However, 5T is considered an incompletely penetrant pathogenic variant that may result in cystic fibrosis when present on the same chromosome as R117H and combined with another pathogenic CFTR variant on the other chromosome. In the absence of R117H, 5T may be associated with CFTR-related disorders depending on the presence of other deleterious variants in the gene. In summary, classification of 5T is based on the following criteria: high frequency variant with incomplete penetrance and variable severity dependent on the presence of other variants in the CFTR gene. Please note: this allele was assessed in the context of healthy population screening. -
not provided Pathogenic:5
This variant is associated with the following publications: (PMID: 11069835, 16020494, 17394391, 7684646, 28152038, 16263954, 7506096, 14685937, 1381723, 17314234, 18306312, 22430190, 12068373, 7739684, 9435322, 28801929, 18507830, 14993601, 7573058, 8556303, 2344617) -
The 11TG-5T variant in IVS8 is the mildest type of 5T variant. When combined with a pathogenic variant on the other chromosome, this variant is not expected to cause classic cystic fibrosis (CF), but may cause a CFTR-related disorder (i.e., an isolated presentation of pancreatitis, congenital bilateral absence of the vas deferens, or mild lung disease) (CFTR2 database). Link to CFTR2 database: http://cftr2.org/ -
- -
CFTR: PM3:Very Strong, PS3:Moderate, PM2:Supporting, BP4 -
- -
Congenital bilateral aplasia of vas deferens from CFTR mutation Pathogenic:3
Variant summary: CFTR c.1210-12[5] (also known as c.5T_TG11 or c.1210-7_1210-6delTT) occurs in the poly T tract in intron 9. 5/5 computational tools predict no significant impact on normal splicing. However, at least one functional study shows a moderate impact to proper CFTR mRNA expression in vitro (Hefferon_2004). The variant has been reported in the literature in numerous individuals affected with Congenital Bilateral Absence of the Vas Deferens, as well as some individuals who are asymptomatic. The variant is associated with CFTR-related disorders when in trans with another severe pathogenic CFTR variant. The penetrance of the c.1210-12[5] variant is influenced by the presence of other variants (e.g. R117H) and the length of the adjacent TG tract on the same allele (in cis). Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014, four of which classified the variant as pathogenic. In addition, ACMG guidelines for reporting CFTR mutations consider the 5T allele as associated as a trans mutation in CBAVD (ACMG guideline_2011). Based on the evidence outlined above, the variant was classified as pathogenic for CBAVD and CFTR-related disorders. -
- -
- -
not specified Pathogenic:1Uncertain:1
The c.1210-34TG[11]T[5] in intron 9 of CFTR is a variant of the polymorphic TG[n ]T[m] region adjacent to exon 10. The T[5] allele has been identified in an ave rage of 4.3% of individuals from a population of European American chromosomes ( Groman 2004) and has been shown to affect splicing in small percentage of transc ripts (Chu 1993). The length of the TG tract modifies the overall risk with lon ger TG repeat sizes (TG 12 and 13) showing the greatest susceptibility to diseas e when present in trans with a pathogenic cystic fibrosis variant (Chu 1992, Cup pens 1998, Groman 2004, Radpour 2007). The combination of the T[5] and TG[11] is least likely to exhibit an abnormal phenotype but a modest increased risk canno t be excluded (Cuppens 1998; Groman 2004). The associated CF-related symptoms ar e congenital bilateral absence of the vas deferens (CBAVD), male infertility, mi ld to classic forms of cystic fibrosis, with severity depending of the CF varian t on the opposite allele (Chillon 1995). In summary, the clinical significance o f the 1210-34TG[11]T[5] is uncertain. -
- -
Cystic fibrosis;C0403814:Congenital bilateral aplasia of vas deferens from CFTR mutation;C2749757:Bronchiectasis with or without elevated sweat chloride 1 Pathogenic:1
- -
Obstructive azoospermia Pathogenic:1
- -
CFTR-related disorder Pathogenic:1
The CFTR c.1210-7_1210-6del variant, also known as c.1210-12T[5] and commonly referred to as the 5T allele, occurs in the poly T tract in intron 9. This variant has been identified in trans with pathogenic variants in CFTR in individuals with a phenotype consistent with CFTR-related disorders, including in men diagnosed with CBAVD and individuals with a range of presentations of cystic fibrosis (PMID: 14685937; 28456595;16126774; 34196078; 27447098). The variant exhibits variable penetrance and is considered to be a disease susceptibility variant dependent on presence of other variants, including the length of the TG tract on the same allele (PMID: 20301428). The highest frequency of this allele in the Genome Aggregation Database is 0.07012 in the African/African-American population which includes 25 homozygotes (version 2.1.1). Functional studies conducted in human cell lines demonstrated that this variant results in abnormal splicing with decreased efficiency of intron 9 splicing (intron 8 with legacy nomenclature) resulting in exclusion of exon 10 in a significant percentage of transcripts (PMID: 34196078; 10556281). This variant has been classified as pathogenic by at least three submitters in ClinVar. Based on the available evidence, the c.1210-7_1210-6del variant is classified as pathogenic for CFTR-related disorders with reduced penetrance and variable severity. -
Hereditary pancreatitis Pathogenic:1
ACMG classification criteria: PS3 supporting, PS4 strong, PM3 very strong -
Cystic fibrosis;C5924204:CFTR-related disorder Pathogenic:1
when the variant is in trans with another CF-causing variation, can either result in CF or in a CFTR-RD -
Congenital bilateral absence of vas deferens Other:1
Variant interpreted as Pathogenic and reported on 07-07-2016 by Lab LabCorp. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
Bronchiectasis with or without elevated sweat chloride 1, modifier of Other:1
- -
Cystic fibrosis;C0238339:Hereditary pancreatitis;C0403814:Congenital bilateral aplasia of vas deferens from CFTR mutation Other:1
Variant classified as Pathogenic and reported on 07-26-2017 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at